Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (TIANJIN PHARMACEUTICAL DA REN T) aktie
600329.SS
StängtTIANJIN PHARMACEUTICAL DA REN T
Market Cap
$30,187,698,176
Om Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (TIANJIN PHARMACEUTICAL DA REN T) aktie
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited engages in the research, development, processing, manufacturing, and sale of traditional Chinese medicine in China. It provides pharmaceutical products for cardiovascular and cerebrovascular, skin wound repair, health preservation, respiratory, digestion, rheumatism and osteodynia, urological, gynecological and pediatric, ophthalmological, tumor, chronic, and other diseases, as well as tonic drugs. The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. The company was founded in 1915 and is based in Tianjin, the People's Republic of China.
Företagsinformation
300193 Tianjin, China
Analytikernas aktierekommendationer
Denna översikt ger en snabb insikt i hur analytiker bedömer aktiens potential baserat på deras senaste analyser och kursmål.